Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Releases Earnings Results

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) issued its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, FiscalAI reports.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

Shares of OACC stock remained flat at $10.76 during trading on Thursday. 141 shares of the company were exchanged, compared to its average volume of 29,698. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $10.30 and a 52-week high of $10.88. The company has a fifty day simple moving average of $10.71 and a 200-day simple moving average of $10.68.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research report on Tuesday, June 30th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Hedge Funds Weigh In On Oaktree Acquisition Corp. III Life Sciences

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at about $5,417,000. Moore Capital Management LP acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 2nd quarter worth approximately $5,502,000. Millennium Management LLC purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at approximately $4,848,000. Lighthouse Investment Partners LLC lifted its holdings in Oaktree Acquisition Corp. III Life Sciences by 88.9% during the 2nd quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company’s stock worth $8,882,000 after buying an additional 400,000 shares during the last quarter. Finally, Sculptor Capital LP raised its position in shares of Oaktree Acquisition Corp. III Life Sciences by 100.0% during the 2nd quarter. Sculptor Capital LP now owns 500,000 shares of the company’s stock worth $5,225,000 after acquiring an additional 250,000 shares in the last quarter.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.